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ABSTRACT
Introduction: Loop ileostomy reduces the morbidity as-
sociated with pelvic sepsis. However, its reversal carries a
10% to 30% complication rate. We present our technique
for laparoscopic ileostomy closure.
Methods: We conducted a retrospective chart review of
subjects undergoing laparoscopic-assisted loop ileostomy
closure between 2006 and 2009. Operating time, length of
hospital stay, return of bowel function, and complication
rates were assessed.
Results: There were 24 (13 males) patients. Average age
was 63 with a BMI of 25.9. Eighteen (75%) had a planned
loop ileostomy, and 6 (25%) were emergent. Average time
to reversal was 135 days. Average length of surgery was 79
minutes (range, 48 to 186), average stay was 4 days and
return to bowel function was 3.6 days. We had no wound
infections. Our complication rate was 29% (n7), and
reoperation rate was 12.5% (n3). Only 1 major compli-
cation occurred, an anastomotic dehiscence.
Conclusion: A thorough, well-visualized lysis of adhe-
sions and mobilization of the stoma and surrounding
small bowel is the main advantage of our approach. We
had no wound infections and no reoperation for bowel
obstruction, which we feel is a direct advantage of our
technique. Our complication rate and surgical time are
comparable to those of the open technique.
Key Words: Ileostomy, Bowel obstruction, Laparoscopy,
Colonoscopy.
INTRODUCTION
Loop ileostomy is a common procedure performed for fecal
stoma diversion for a variety of reasons but primarily for
colorectal surgery, low anterior resection, high-risk patients,
and others. The incidence of clinical anastomotic leak after
colorectal resection has been reported to range from 1.8% to
15%.1 Morbidity associated with colorectal anastomotic leaks
include pelvic sepsis, intraabdominal abscess, infertility, pel-
vic fibrosis, and stricture formation. A defunctioning loop
ileostomy is often created to reduce the incidence of anas-
tomotic leaks and limit the deleterious effects in case of
anastomotic leak.2 Routine use of defunctioning ileostomy
has led to decreases in the incidence of pelvic sepsis, anas-
tomotic disruption, and lower mortality with pelvic opera-
tions.2–4 However, ileostomy reversal requires a second op-
eration and has significant morbidity, with complication rates
reported in the range of 10% to 30%.5 Studies examining
ileostomy reversal reveal a wide range of methodologies and
complication rates. The difficulty in reviewing the pertinent
literature arises in part because of multiple complex and
possibly confounding factors including preoperative diagno-
sis, reason for ileostomy formation, comorbidities, and clo-
sure technique.
Minimally invasive techniques have revolutionized and pro-
vided clear benefits to the art of surgical practice. At the
Texas Endosurgery Institute (TEI), we have developed a
laparoscopic approach to ileostomy closure. We consider
one of the most important reasons to perform this procedure
laparoscopically is the ease of adhesiolysis; the visualization
of the loop ileostomy is easier thru laparoscopy. All ileos-
tomy closures involve some form of adhesiolysis, and care
must be taken while doing this. The purpose of the adhesi-
olysis is to make it easier to perform the ileostomy takedown,
not to prevent future small bowel obstruction. We describe
our technique and outcomes with laparoscopic ileostomy
closure and demonstrate no wound infections (0%) with
equivalent postoperative complications, length of hospital
stay, and return of bowel function compared with reports of
open ileostomy closure. Specific data points including rea-
sons for ileostomy formation, elective versus emergent op-
eration, neoadjuvant therapies, and technical complications
were gathered. Outcomes, measured by operating time,
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SCIENTIFIC PAPERlength of hospital stay, return of bowel function, and com-
plication rates were assessed.
METHODS
A retrospective chart review of subjects undergoing laparo-
scopic loop ileostomy closure at a single institution (TEI, San
Antonio, Texas) between 2006 and 2009 was conducted
under an IRB-exempt study. Appropriate demographic in-
formation pertaining to sex, age, BMI, preoperative diagno-
sis, and comorbidities was obtained. Patient-specific data
points including reasons for ileostomy formation, elective
versus emergent operation, neoadjuvant therapies, and tech-
nical complications were gathered. Outcomes, measured by
operating time, length of hospital stay, return of bowel func-
tion, and complication rates were assessed.
Wounds were monitored during daily rounds and follow-up
visits for signs of infection, which we defined as cellulitis,
induration, or purulent discharge from the former stoma site.
Return of bowel function was defined as first passage of
flatus or bowel movement with tolerance of an oral diet.
Ileus was defined as delayed return of bowel function, with
abdominal distention, nausea, intolerance of an oral diet, or
radiographic evidence of dilated bowel without clear ob-
struction. Bowel obstruction was defined as delayed return
of bowel function, with abdominal distention, nausea, intol-
erance of an oral diet, and radiographic evidence of dilated
bowel with clear obstruction.
Technique
Preoperatively, all patients undergo colonoscopy and/or
Gastrografin enema. We do not routinely perform contrast
studies through the ileostomy. A thorough discussion with
the patient concerning the risks, benefits, and alternatives
to stoma reversal is completed as well. All patients are
advised to observe a clear liquid diet for one day prior to
surgery, and no bowel prep of any kind. All patients
receive one preoperative dose of first-generation cepha-
losporin unless allergic to penicillin. We position the pa-
tient in the lithotomy position with both arms tucked and
thighs straight or at the most 15 * degrees from the hip.
The skin around the stoma is sutured closed and an
op-site clean adhesive bandage applied. The remainder of
the abdomen is prepped and draped in sterile fashion.
The procedure begins with placement of a Veress needle
in the left upper quadrant lateral to the rectus sheath (on
Palmer’s point). Pneumoperitoneum is achieved to a pres-
sure of 14 mm Hg using CO2. The Veress needle is ex-
changed for a 5-mm trocar. A 5-mm, straight laparoscope
is introduced, and the abdomen is examined. Another
5-mm trocar is placed in strategic locations to facilitate
adhesiolysis and reduction of parastomal hernia if en-
countered. Most commonly, our configuration involves
only a third 5-mm trocar placed in the left lower quadrant.
We perform enough adhesiolysis to be able to work freely
in the abdomen, which is needed in most cases. Most
adhesiolysis can be accomplished using laparoscopic
shears through a single 5-mm port. A thorough adhesioly-
sis is completed with minimal use of electrocautery. We
lyse the serosa-peritoneal adhesions at the stoma site as
well. If a parastomal hernia is encountered, it is reduced
into the abdomen. The loop of terminal ileum is examined
and any intraloop adhesions of the small bowel are lysed
for easier mobilization and the length of the resection
determined. With this method of mobilization, the only
remaining significant attachment is the mucocutaneous
junction. Once the adhesiolysis is performed, an on-the-
table colonoscopy is done to examine the distal anasto-
mosis. If a stricture is identified, or known by preoperative
studies, it is addressed at the time of surgery by serial
balloon dilation. We prefer an on-the-table colonoscopy
because the patient is already under anesthesia, compared
to performing a preoperative colonoscopy. At this point,
the mucocutaneous junction is taken down sharply and
the stoma spout elevated out of the field. A GIA is used to
create a side-to-side functional end-to-end ileoileostomy
through the ileostomy site. A limited enterectomy is per-
formed to include the former exteriorized stoma. The
bowel is then reduced into the abdomen. The fascia at the
stoma site is partially closed with a running 1-Vicryl su-
ture. A 10-mm trocar is placed through the partially closed
stoma site, and a portion of covered polypropylene mesh
is introduced through this trocar into the abdominal cav-
ity. The 2-layer closure of the fascia at the stoma site is
then completed, and the wound copiously irrigated with
Betadine. The mesh is then positioned over the inside of
the now closed fascial defect and secured using a spiral
tacker. We do not routinely use transfascial sutures to
secure the mesh with this procedure. The abdomen is
again inspected to ensure hemostasis, and any blood or
irrigant is evacuated. All trocar sites are closed with 4-0
Monocryl sutures. The stoma site skin is closed using skin
clips. Sterile dressings are applied.
RESULTS
From 2006 to 2009, a total of 24 (13 males) patients
underwent laparoscopic loop ileostomy closure. Average
age was 63 with an average BMI of 25.9 (Table 1).
Eighteen patients (75%) had a planned loop ileostomy for
fecal diversion. Twelve of these subjects had a rectal
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had a low (10cm from the anal verge) anastomosis. The
remaining 6 had elective sigmoid colon resection for re-
current diverticulitis, but were felt to be at high risk for
anastomotic complications due to nutritional status, co-
morbidities, or difficulty of dissection. Six (25%) patients
underwent an emergent operation for which fecal diver-
sion in addition to colon resection was deemed the best
option. These 6 included diagnoses of perforated diver-
ticulitis,2 obstructing colon cancer, perforated colon can-
cer, toxic megacolon, and lower gastrointestinal bleeding.
A diverting loop ileostomy was done in 2 additional sub-
jects where the initial operative plan did not include fecal
diversion. One subject was found to have an anastomotic
leak after a stapled colorectal anastomosis, and the other
subject had a rectal injury during an attempted transvag-
inal extraction. The average time interval between loop
ileostomy formation and reversal was 135 days. Nine sub-
jects had previous open abdominal surgeries.
Average length of surgery was 79 minutes (range, 48 to
186). Only 4 cases exceeded over 100 minutes. All 4 of
these subjects had multiple previous open abdominal sur-
geries and required significant adhesiolysis at the time of
ileostomy reversal. Despite the extensive adhesiolysis re-
quired, these 4 cases were completed without conversion
to an open approach and did not require extension of the
peristomal fascial incision. When these 4 cases are ex-
cluded, our average operating time was 64 minutes. Sig-
nificant also is our practice of performing an intraopera-
tive colonoscopy on all ileostomy closures. Six subjects
were found to have a stricture on preoperative barium
enema and were managed by intraoperative colonoscopy
and balloon dilation.
No cases required conversion to laparotomy or extension of
the fascial incision at the ileostomy site. Average length of
hospital stay was 4 days. Return of bowel function, evi-
denced by passage of flatus or bowel movement, occurred
on average on postoperative day 3.6. We routinely close the
skin over the ileostomy site, and even with mesh reinforce-
ment of the fascial closure, had no wound infections.
Patients were seen in follow-up at 1 month, 3 months, and
then 1 year. Our total complication rate was 29% (n7)
and reoperation rate of 12.5% (n3) (Table 2).
Four subjects had minor complications, which included 2
patients with ileus that resolved without surgical interven-
tion, an episode of atrial fibrillation, and urinary retention.
One major complication, and anastomotic dehiscence, oc-
curred in one patient. This required emergent open explo-
ration, bowel resection, and re-creation of intestinal continu-
ity. One patient was found to have an incisional hernia at the
former stoma site at 1-year follow-up and had an uncompli-
cated elective repair. There were no postoperative bowel
obstructions, deaths, or wound infections.
DISCUSSION
It is common practice among many surgeons to utilize
fecal stream diversion by using a loop ileostomy. Many
methods of ileostomy reversal have been described in the
literature. We have described a single-center experience
with laparoscopic ileostomy reversal.
Although ileostomy reversal is a common operation, the
complication rate is significant. The rate of wound infec-
tion in ileostomy reversal has been reported as high as
40%.6,7 Considering the frequency at which diverting il-
eostomy is used, methods to reduce the rate of wound
infection are of paramount importance. We had no wound
infections in our population. We have our patients adhere
to a clear liquid diet 1 day prior to surgery. All patients
receive 1 dose of preoperative antibiotics. We suture the
ileostomy spout closed before beginning the procedure
and exclude the spout from the sterile field. These prac-
Table 1.
Demographics
Sex M 13/F 11
Age 63
BMI 25.9
Albumin 3.2
Length of surgery 79.6
Table 2.
Complications
Complication Number
Major
Anastomotic Dehiscence 1
Stoma site hernia 1
Minor
Urinary Retention 2
Atrial Fibrillation 1
Ileus 2
Re-operations 3
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our low infection rate success to our laparoscopic ap-
proach. By definition, ileostomy reversal is a contami-
nated procedure, thus the reported wound infection rate
is not surprising. We perform laparoscopic adhesiolysis
and mobilization of the small bowel to the point of having
only the mucosa-skin interface of the ileostomy spout as
the tethering point. The circumstomal incision is not made
until adhesiolysis is done and the bowel fully mobilized.
This results in less manipulation of the stoma and less
trauma to the abdominal wall when the circumstomal
incision is made and the ileum is mobilized through the
fascial opening. We feel this results in less contamination
of the wound and contributes greatly to preventing post-
operative wound infection.
There is debate about primary versus delayed primary or
secondary closure of the stoma site, with varying results
even in randomized studies. In general, primary closure of
the stoma site has resulted in increased wound infection
rates. However, Lahat et al6 demonstrated with a random-
ized study that there was no significant difference be-
tween primary closure versus delayed primary closure of the
stoma site. Wound infection increases the cost associated
with ileostomy reversal and prolongs hospital stays. We also
feel that delayed primary closure or closure by secondary
intent places an undue burden on the patient, and increases
utilization of nursing care, both while in the hospital and
home health services. Thus, we elect to close the stoma site
at the time of reversal. Our infection rate was zero; thus,
we feel primary closure of the stoma site can be done
safely with laparoscopic ileostomy reversal.
Our mean operating time was longer than what is re-
ported in the literature.8–11 Miyano et al8 reported a tech-
nique of laparoscopic-assisted ileostomy reversal in chil-
dren with an average operating time of 23 minutes.
Pokorny et al,9 Mansfield et al,10 and Hasegawa et al11
report open ileostomy reversal with operative times rang-
ing from 35 minutes to 60 minutes. When the 4 subjects
from our population who had multiple open operations
are excluded, our average operating time was 64 minutes,
which is closer to reported ranges. Significant also is our
practice of performing an intraoperative colonoscopy on
all ileostomy reversals, which was not routinely done in the
above-mentioned published reports. We feel that perform-
ing a colonoscopy allows for evaluation and intervention, if
needed, of the colonic anastomosis. If we were to exclude
the colonoscopy from the procedure, our operating times
would be equivalent to the operative times reported in the
literature. While our operating times may be longer than
those in other published reports, the benefit of an intraop-
erative colonoscopy and the tradeoff of a thorough adhesi-
olysis in preventing wound infections and postoperative
bowel obstruction are well worth the extra time.
Most investigators recommend an interval of at least 7
weeks to 12 weeks between ileostomy formation and
reversal. This is to allow recovery from the initial surgery
or inciting event as well as to lessen adhesions and
edema.2 Our time to reversal was longer than that in most
reports. It is difficult to assess a benefit to early ileostomy
reversal from the literature. However, Mansfield et al10
demonstrated increased complication rates associated
with earlier reversal of ileostomy. Our approach to rever-
sal was to allow sufficient recovery time between the
initial operation and reversal. A total of 6 subjects under-
went diverting ileostomy as part of an emergency opera-
tion. These subjects presented with sepsis and severe
debilitation from perforating colon cancer, diverticulitis,
and a malignant colonic obstruction. Their subsequent
hospital course and post discharge recovery was challenging.
Eight subjects had neoadjuvant chemoradiation, and 7 had
postoperative chemotherapy. We allow at least 8 weeks be-
tween initial operation and completion of adjuvant therapies to
improve functional and nutritional status. We have also found
that with a longer delay, the adhesions are less dense at the time
of reoperation. No subjects had prereversal complications, such
as dehydration and electrolyte abnormalities; thus, there was no
disadvantage to waiting longer to reverse the ileostomy. Ex-
tending the time to ileostomy reversal allows the patient to fully
recover from the initial surgery and associated events, complete
adjuvant therapy, improve their nutritional status, and allows
time for the adhesions to become less dense. We feel this is
better for the patient and contributes greatly to our results.
Overall complication rates after ileostomy reversal range
between 10% to 33%, with an all-cause reoperation rate of
up to 12.5%.10 Complications have been shown to be
higher in subjects with increasing age, multiple comor-
bidities, and whose stomas were created as part of an
emergency operation.10 Our overall complication rate was
within the range reported in the literature. Most of our
complications were minor and were managed with no
operative or medical therapy. Our reoperation rate was
also within ranges reported in the literature, although at
the higher end of that range. Despite prophylactically
reinforcing the stoma site with a coated mesh, we had 2
occurrences of incisional hernia at the former stoma site at
1-year follow-up. An ostomy is by definition a controlled
hernia. It has been proven that hernias 4cm should be
repaired with mesh as opposed to primary closure.
Wound infection certainly predisposes to fascial dehis-
cence thus hernia formation. We had no wound infections
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between preoperative diagnosis, comorbidities, or use of
adjuvant chemotherapy, and stoma-site hernia formation.
We thus attribute these hernias to technical errors. One
subject had a devastating anastomotic leak, resulting in
intraabdominal sepsis and a very prolonged hospital
course. This subject had a complex surgical history com-
plicated by an anastomotic leak after previous colorectal
surgery resulting in intraabdominal sepsis. Despite a pro-
longed interval from ileostomy formation to reversal, this
subject was functionally and nutritionally debilitated from
her previous postsurgical course. We found no correlation
between preoperative diagnosis and complication. We
did find a low albumin level (2.8) in all subjects who
required reoperation.
Postileostomy reversal bowel obstruction rates are re-
ported to be as high as 15%.5 The definition of bowel
obstruction and technique of ileostomy closure varies
across studies, leading to methodological difficulties in
examining this complication. Most episodes of postoper-
ative obstruction in the literature are managed conserva-
tively, but the reoperation rate is not insignificant. Return
of bowel function amongst our subjects occurred on av-
erage between postoperative day 3 to 4, with a mode of 2
days. Two subjects had delayed return of bowel function,
with return of full bowel function at postoperative day
6 and 7. No subjects required reoperation for obstruc-
tion. We attribute this to our technique. By performing
a wide lysis of adhesions, potential sources of obstruc-
tion are eliminated. When done via a strictly open
approach, mobilizing the ileostomy is often a blind
procedure. With laparoscopy, we can address any ad-
hesions that may become points of obstruction. We can
manipulate the bowel with less trauma, which we also
feel contributes to earlier return of bowel function.
There is no consensus as to whether the ileostomy
should be closed by stapled or hand-sewn technique.
We elect to perform a limited enterectomy with a sta-
pled side-to-side anastomosis. This creates a widely
patent ileoileostomy, less likely to obstruct as a result of
luminal narrowing or anastomotic edema, also contrib-
uting to early return of bowel function.
CONCLUSION
Ileostomy for fecal stream diversion is common practice.
Ileostomy reversal is a common procedure but associated
with significant morbidity. We have presented our method
of laparoscopic approach to ileostomy reversal. A thor-
ough, well-visualized lysis of adhesions and mobilization
of the stoma and surrounding small bowel is the main
advantage of our approach. We have demonstrated no
wound infections and no reoperation for bowel obstruc-
tion, which we feel is a direct advantage of our technique.
Compared with reports of open ileostomy reversal, we
have also demonstrated equivalent results with complica-
tion rates, and return of bowel function. We were able to
perform ileostomy reversal by our technique, including
intraoperative colonoscopy, in comparable time as well.
This was a small retrospective case review, and the po-
tential to lower the significant morbidity associated with
this common procedure warrants further evaluation.
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